Oligodeoxyribonucleotides, Antisense
"Oligodeoxyribonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
| Descriptor ID |
D020319
|
| MeSH Number(s) |
D13.150.200.640 D13.150.480.640 D13.444.308.150.640 D13.444.600.150.200.640 D13.444.600.150.640.640 D13.695.578.424.480.640 D27.720.470.530.600.150.200.640 D27.720.470.530.600.150.640.640
|
| Concept/Terms |
Oligodeoxyribonucleotides, Antisense- Oligodeoxyribonucleotides, Antisense
- Antisense OligoDNA
- OligoDNA, Antisense
- Anti-Sense Oligodeoxyribonucleotides
- Anti Sense Oligodeoxyribonucleotides
- Oligodeoxyribonucleotides, Anti-Sense
- Oligodeoxyribonucleotide, Antisense
- Antisense Oligodeoxyribonucleotide
- Antisense Oligodeoxyribonucleotides
|
Below are MeSH descriptors whose meaning is more general than "Oligodeoxyribonucleotides, Antisense".
- Chemicals and Drugs [D]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Antisense Elements (Genetics) [D13.150]
- DNA, Antisense [D13.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.150.200.640]
- Oligonucleotides, Antisense [D13.150.480]
- Oligodeoxyribonucleotides, Antisense [D13.150.480.640]
- Nucleic Acids [D13.444]
- DNA [D13.444.308]
- DNA, Antisense [D13.444.308.150]
- Oligodeoxyribonucleotides, Antisense [D13.444.308.150.640]
- Nucleic Acid Probes [D13.444.600]
- Antisense Elements (Genetics) [D13.444.600.150]
- DNA, Antisense [D13.444.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.200.640]
- Oligonucleotides, Antisense [D13.444.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.640.640]
- Nucleotides [D13.695]
- Polynucleotides [D13.695.578]
- Oligonucleotides [D13.695.578.424]
- Oligonucleotides, Antisense [D13.695.578.424.480]
- Oligodeoxyribonucleotides, Antisense [D13.695.578.424.480.640]
- Chemical Actions and Uses [D27]
- Specialty Uses of Chemicals [D27.720]
- Laboratory Chemicals [D27.720.470]
- Molecular Probes [D27.720.470.530]
- Nucleic Acid Probes [D27.720.470.530.600]
- Antisense Elements (Genetics) [D27.720.470.530.600.150]
- DNA, Antisense [D27.720.470.530.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.200.640]
- Oligonucleotides, Antisense [D27.720.470.530.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.640.640]
Below are MeSH descriptors whose meaning is more specific than "Oligodeoxyribonucleotides, Antisense".
This graph shows the total number of publications written about "Oligodeoxyribonucleotides, Antisense" by people in this website by year, and whether "Oligodeoxyribonucleotides, Antisense" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oligodeoxyribonucleotides, Antisense" by people in Profiles.
-
Andrews DW, Judy KD, Scott CB, Garcia S, Harshyne LA, Kenyon L, Talekar K, Flanders A, Atsina KB, Kim L, Martinez N, Shi W, Werner-Wasik M, Liu H, Prosniak M, Curtis M, Kean R, Ye DY, Bongiorno E, Sauma S, Exley MA, Pigott K, Hooper DC. Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res. 2021 04 01; 27(7):1912-1922.
-
Morin-Brureau M, Hooper KM, Prosniak M, Sauma S, Harshyne LA, Andrews DW, Hooper DC. Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide. Cancer Immunol Immunother. 2015 Apr; 64(4):447-57.
-
Harshyne LA, Hooper KM, Andrews EG, Nasca BJ, Kenyon LC, Andrews DW, Hooper DC. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother. 2015 Mar; 64(3):299-309.
-
Davidson W, Ren Q, Kari G, Kashi O, Dicker AP, Rodeck U. Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos. Cell Cycle. 2008 May 01; 7(9):1224-30.
-
Liao L, Li Z. Correlation between gene silencing activity and structural features of antisense oligodeoxynucleotides and target RNA. In Silico Biol. 2007; 7(4-5):527-34.
-
Israel Y, Kandov Y, Khaimova E, Kest A, Lewis SR, Pasternak GW, Pan YX, Rossi GC, Bodnar RJ. NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides. 2005 Jul; 26(7):1167-75.
-
Garver E, Cao QN, Aini M, Zhou F, Israel Y. Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism results in an aversion to ethanol. J Exp Med. 2001 Sep 03; 194(5):571-80.
-
Andrews DW, Resnicoff M, Flanders AE, Kenyon L, Curtis M, Merli G, Baserga R, Iliakis G, Aiken RD. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol. 2001 Apr 15; 19(8):2189-200.